Is cannabidiol worth a trial in Rasmussen encephalitis?

We report 3 patients (age 8, 13 and 14 years) with drug-resistant epilepsy due to Rasmussen encephalitis treated with cannabidiol in addition to their current antiseizure medication (ASM). In all three patients we observed a positive effect, which seemed to surpass the efficacy that would be expected from a different fourth or fifth antiseizure drug used during the course of the disease. Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Citation

Christine Prager, Fabienne Kühne, Anna Tietze, Angela M Kaindl. Is cannabidiol worth a trial in Rasmussen encephalitis? European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. 2022 Mar;37:53-55

Mesh Tags

Substances

PMID: 35093803

search → result